Top Authors

• Most frequent coverage on NRPH

• 
  Centient Biotech Investor (10 followers)

  • Biotech Day in Review: New River/Shire Win Approval for ADHD Drug (Tue, Feb 27)
  • Biotech Day in Review: Shire Buys New River for $2.6 Billion (Wed, Feb 21)

  More by Centient Biotech Investor on NRPH »
• 
  George Gutowski (25 followers)

  • Weekend Follies: Press Releases While Nobody’s Looking (Mon, Jun 19)

  More by George Gutowski on NRPH »
• 
  SA Editor Miriam Metzinger (560 followers)

  • Jim Cramer's Mad Money Lightning Round Picks, Feb. 21 (Wed, Feb 21)

  More by SA Editor Miriam Metzinger on NRPH »

• Most followed authors on NRPH

• 
  Joseph Shaefer (2623 followers)

  • Global Warming: Investment Implications (Thu, Aug 20)

  More by Joseph Shaefer on NRPH »
• 
  SA Editor Miriam Metzinger (560 followers)

  • Jim Cramer's Mad Money Lightning Round Picks, Feb. 21 (Wed, Feb 21)

  More by SA Editor Miriam Metzinger on NRPH »
• 
  Stockerblog (457 followers)

  • Analysis of a Ten Bagger Stock: New River Pharmaceuticals (Mon, Feb 12)

  More by Stockerblog on NRPH »

• Newest authors on NRPH

• 
  Joseph Shaefer (2623 followers)

  • Global Warming: Investment Implications (Thu, Aug 20)

  More by Joseph Shaefer on NRPH »
• 
  Mark Senak (1 follower)

  • FDA Approvable Letters for New River Pharmaceuticals, Shire, Allergan and Perrigo (Sun, Dec 24)

  More by Mark Senak on NRPH »
• 
  Centient Biotech Investor (10 followers)

  • Biotech Day in Review: New River/Shire Win Approval for ADHD Drug (Tue, Feb 27)
  • Biotech Day in Review: Shire Buys New River for $2.6 Billion (Wed, Feb 21)

  More by Centient Biotech Investor on NRPH »

• Most commented on NRPH

• 
  Joseph Shaefer (2623 followers)

  • Global Warming: Investment Implications (Thu, Aug 20)

  More by Joseph Shaefer on NRPH »